MarginsXMarginsX
Home › Markets › Health Care › NIVF

NewGenIvf Group Limited (NIVF)

NIVF trades on Nasdaq in Health Care, Misc Health and Biotechnology Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.2050
-11.33% on the day
Market cap
$2.0M
Nano cap
Revenue · 2025
$4.7M
-13.0% on 2024
Net income · 2025
$9.9M
209.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1981662/000121390026037687/0001213900-26-037687-index.htm. Net income: SEC 20-F (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerNIVF on Nasdaq
SectorHealth Care
IndustryMisc Health and Biotechnology Services
CountrySingapore
IPO yearNot reported by the screener
SEC CIK0001981662
SEC industry codeServices-Misc Health & Allied Services, NEC
Incorporated inVirgin Islands, British

Financials · 2025

LineValue
Revenue$4.7M
Net income$9.9M
Operating income-$10.7M
Net margin209.0%
Operating margin-226.9%
Revenue growth-13.0%
Cash$759K
Total assets$32.7M
P/E (computed)0.2×
P/S (computed)0.4×

Warning signs

Cash runway
0.8 months
$759K cash at December 31, 2025
Share count, 1 year
See the dilution note
Going-concern doubt
No
20-F filed March 31, 2026
Insider net buying, 12 months
$408K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-03-31
Cash and burn$759K cash; operating cash flow -$2.7M a quarter.Report 2025-12-31
Shares outstandingNo cover-page share count in XBRLCover page 2025-12-31
Reverse splits, 3 years9; latest 1-for-8 on 2026-10-23Source 2026-10-23
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-10-27
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorJ&S Associate PLT, Kuala Lumpur, MalaysiaPCAOB Form AP 2026-10-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $527K, sold $119K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$4.7M$9.9M-$10.9M$759K$519K$4.7M20-F 2026-03-31
FY 2024
2024-12-31
$5.4M-$525K-$8.3M$458K$582K$5.4M20-F 2026-03-31
FY 2023
2023-12-31
$5.1M$130K-$1.8M$54KNo debt tags$5.1M20-F 2026-03-31
FY 2022
2022-12-31
$5.9M$459K$1.7M$28KNo debt tags$5.9M20-F/A 2025-05-15
FY 2021
2021-12-31
$4.1M-$533$1.4M$29KNo debt tags$4.1M20-F 2024-08-20

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
REGISTRATION STATEMENT
F-32026-10-27
Latest annual report
ANNUAL REPORT
20-F2026-03-31
Latest quarterly / interim
REPORT OF FOREIGN PRIVATE ISSUER
6-K2026-11-16

Source: SEC EDGAR submissions feed, 198 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-49.5%
1 month-85.2%
3 months-99.6%
Year to date-100.0%
1 year-100.0%
From 52-week high-100.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
NIVFWNewGenIvf Group Limited Warrants$0.0075

Peers in Misc Health and Biotechnology Services

TickerCompanyPriceDayMarket cap
MGRXMangoceuticals Inc.$0.1603+3.42%$3.6M
CCELCryo-Cell International Inc.$4.55-6.19%$36.7M
PARKPark Dental Partners Inc.$19.72-8.24%$109.2M
VMDViemed Healthcare Inc. Common Shares$9.15-0.22%$346.7M
AGLagilon health inc.$116.75+0.94%$2.0B
PGNYProgyny Inc.$37.15+2.68%$2.7B
SHCSotera Health Company$16.25-2.17%$4.6B
DVADaVita Inc.$174.22-0.19%$11.0B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier